Adhara Kaeli
Phenotypic drug discovery has emerged as a promising approach to identify novel therapeutics by focusing on the functional outcomes of drug action rather than specific molecular targets. This abstract explores the rationale behind phenotypic screening, highlighting its advantages in uncovering complex mechanisms of action, identifying unexpected targets and mitigating issues of target validation. Furthermore, it discusses recent advancements in phenotypic screening technologies, including high-throughput assays and computational approaches, which have accelerated the discovery of diverse compounds with therapeutic potential. By embracing phenotypic drug discovery, researchers can harness the complexity of biological systems to develop innovative treatments for a wide range of diseases, ultimately paving the way for next-generation therapeutics.
Comparte este artículo